Skip to main content
SpringerLink
Log in

Pharmacologic Therapy for Anorexia Nervosa

  • Chapter
The Management of Eating Disorders and Obesity

Part of the book series: Nutrition ◊ and ◊ Health ((NH))

  • 204 Accesses

Abstract

People with anorexia nervosa have abnormal eating behaviors with associated cognitive misconceptions concerning body image and disturbances of mood, as well as alterations of a wide variety of hormonal and metabolic systems (see Chapter 5 for a further description of anorexia nervosa). Currently, many investigators conceptualize these disorders as being due to a combination of cultural-social, psychological, and biological factors (1,2). In general, the response of patients with anorexia nervosa to psychotherapeutic or pharmacological treatments has been limited. The purpose of this chapter is to review the evidence for the efficacy of available drug treatments for anorexia nervosa and guidelines for pharmacological therapy (Table 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Garner DM, Garfinkel PE. The eating attitudes test: an index of the symptoms of anorexia nervosa. Psychol Med 1979; 9: 273–279.

    Article  CAS  Google Scholar 

  2. Ploog D. The Psychobiology of Anorexia Nervosa. In: Pirke KM, Ploog D, eds. Springer-Verlag, Berlin, NY, 1984, pp. 1–3.

    Google Scholar 

  3. Johanson AJ, Knorr NJ. L-Dopa as treatment for anorexia nervosa. In: Vigersky RA, ed. Anorexia Nervosa. Nervosa, Raven, New York, NY, 1977, pp. 363–372.

    Google Scholar 

  4. Redmond DE, Swann A, Heninger GR. Phenoxybenzamine in anorexia nervosa. Lancet 1976; 2: 397.

    Google Scholar 

  5. Green RS, Rau JH. Treatment of compulsive eating disturbances with anticonvulsant medication. Am J Psychol 1974; 131: 428–432.

    CAS  Google Scholar 

  6. Green RS, Rau JH. The use of diphenylhydantoin in compulsive eating disorders: further studies in anorexia nervosa. In: Vigersky RA, ed. Anorexia Nervosa. Nervosa, Raven, New York, NY, 1977, pp. 377–385.

    Google Scholar 

  7. Wulliemier JF, Rossel F, Sinclair K. La therapie comportementale de l’ anorexia. J Psychsom Res 1975; 19: 267–272.

    Article  CAS  Google Scholar 

  8. Moore R, Mills IH, Forster A. Naloxone in the treatment of anorexia nervosa: Effect on weight gain and lipolysis. J Roy Soc Med 1981; 74: 129–131.

    CAS  Google Scholar 

  9. Halmi KA. Anorexia nervosa. In: Kaplan HI, Freedman AM, Sadock RJ, eds. Comprehensive Textbook of Psychiatry, Vol. 2, 3rd ed. Williams & Wilkins, Baltimore, MD, 1980.

    Google Scholar 

  10. Hsu LKG. The treatment of anorexia nervosa. Am J Psychiatry 1986; 143: 573–581.

    CAS  Google Scholar 

  11. Russell GFM, Szmukler GI, Dare C, Eisler I. An evaluation of family therapy in anorexia nervosa and bulimia nervosa. Arch Gen Psychiatry 1987; 44: 1047–1056.

    Article  CAS  Google Scholar 

  12. Gowers S, Norton K, Halek C, Crisp AH. Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. Int J Eat Disord 1994; 15: 165–177.

    Article  CAS  Google Scholar 

  13. Treasure J, Todd G, Brolly M, Tiller J, Nehmed A, Denman F. A pilot study of a randomized trail of cognitive analytical therapy vs educational behavioral therapy for adult anorexia nervosa. Behav Res Ther 1995; 33 (4): 363–367.

    Article  CAS  Google Scholar 

  14. Kaye WH, Weltzin TE, Hsu LKG, Sokol MS, McConaha C, Plotnicov KH. Relapse prevention with fluoxetine in anorexia nervosa: a double-blind placebo-controlled study. Abstracts of the 1996 Meeting at the American Psychiatric Association, Washington, DC, p. 178.

    Google Scholar 

  15. Vandereychken W, Pierlott R. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. Acta Psychiatr Scand 1982; 66: 445–450.

    Article  Google Scholar 

  16. Vandereychken W. Neuroleptics in the short-term treatment of anorexia nervosa: a double-blind, placebo controlled study with sulphide. Brit J Psychol 1984; 144: 288–292.

    Article  Google Scholar 

  17. Gross H, Ebert MH, Faden VB. A double-blind trial of delta-9-tetrahydrocannabinol in primary anorexia nervosa. J Clin Psychopharm 1983; 3: 165–171.

    Article  CAS  Google Scholar 

  18. Casper RC, Schlemmer RF, Javaid JI. A placebo-controlled, crossover study of oral clonidine in acute anorexia nervosa. Psychol Res 1987; 20: 249–260.

    CAS  Google Scholar 

  19. Szmukler GI, Young GP, Lichenstein M, Andrews JT. A serial study of gastric emptying in anorexia and bulimia nervosa. Aust N Z J Med 1990; 20: 220–225.

    Article  CAS  Google Scholar 

  20. Domstad PA, Shih WJ, Humphries L, DeLand FH, Digenis GA. Radionuclide gastric emptying studies in patients with anorexia nervosa. J Nucleic Med 1987; 28: 816–819.

    CAS  Google Scholar 

  21. Russell DM, Freedman ML, Feiglin DH, Jeejeebhoy KN, Swinson RP, Garfinkel PE. Delayed gastric emptying and improvement with domperidone in a patient with anorexia nervosa. Am J Psychiatry 1983; 140: 1235–1236.

    CAS  Google Scholar 

  22. Saleh JW, Lebwohl P. Metoclopramide-induced gastric emptying in patients with anorexia nervosa. Am J Gastroenterol 1980; 74: 127–132.

    CAS  Google Scholar 

  23. Stacher G, Bergmann H, Wiesnagrotzki S, Kiss A, Schneider C, Mittelbach G, et al. Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa. Gastroenterology 1987; 92: 1000–1006.

    CAS  Google Scholar 

  24. Strober M, Katz JL. Depression in the eating disorders: A review and analysis of descriptive, family, and biological findings. In: Garner DM, Garfinkel PE, eds. Diagnostic Issues in Anorexia Nervosa and Bulimia Nervosa. Brunner/Mazel, New York, NY 1988.

    Google Scholar 

  25. Rothenberg A. Differential diagnosis of anorexia nervosa and depressive illness: a review of 11 studies. Compr Psychiatry 1988; 29: 427–432.

    Article  CAS  Google Scholar 

  26. Swift WJ, Andrews D, Barklage NE The relationship between affective disorder and eating disorders: a review of the literature. Am J Psychol 1986; 143: 290–299.

    CAS  Google Scholar 

  27. Strober M. Personality and symptomatological features in young, nonchronic anorexia nervosa patients. J Psychosom Res 1980; 24: 353–359.

    Article  CAS  Google Scholar 

  28. Hudson JI, Pope HG, Jonas JM, Yurgelum-Todd D. Phenomenologic relationship of eating disorders to major affective disorder. Psychiatry Res 1983; 9: 345–354.

    Article  CAS  Google Scholar 

  29. Solyom LS, Freeman RJ, Miles JE. A comparative psychometric study of anorexia nervosa and obsessive neurosis. Can J Psychiatry 1982; 27: 282–286.

    CAS  Google Scholar 

  30. Toner BB, Garfinkel PE, Garner DM. Long term follow-up of anorexia nervosa. Psychosom Med 1986; 48: 520–529.

    CAS  Google Scholar 

  31. Kasvikis YG, Tsakiris F, Marks IM. Past history of anorexia nervosa in women with obsessive compulsive disorder. Int J Eat Disord 1986; 5: 1069–1075.

    Article  Google Scholar 

  32. Kaye WH, Gwirtsman HE, George DT, Ebert MH. Altered serotonin activity in anorexia nervosa after long-term weight restoration. Arch Gen Psych 1991; 48: 556–562.

    Article  CAS  Google Scholar 

  33. Zohar J, Insel TR. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol Psychiatry 1987; 22: 667–687.

    Article  CAS  Google Scholar 

  34. Moore R. Amitriptyline therapy in anorexia nervosa. Am J Psychol (1977); 13: 1303–1304.

    Google Scholar 

  35. Needlemen HL, Waber D. The use of amitriptyline in anorexia nervosa. In: Vigersky RA, ed. Anorexia Nervosa. Raven, New York, NY, 1977.

    Google Scholar 

  36. Beiberman J, Herzog DB, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF, et al. Amitriptyline in the treatment of anorexia nervosa: a double-blind placebo-controlled study. J Clin Psychopharm 1985; 5: 10–16.

    Google Scholar 

  37. Gross HA, Ebert MH, Faden VB, Goldberg SC, Nee LE, Kaye WH. A double blind controlled trial of lithium carbonate in primary anorexia nervosa. J Clin Psychopharmacol 1981; 1: 376–381.

    Article  CAS  Google Scholar 

  38. Kaye WH, Weltzin T, Hsu LKG. Anorexia nervosa. In: Hollander E, ed. Obsessive-Compulsive Related Disorders. American Psychiatric Press, Washington, DC, 1993, pp. 49–70.

    Google Scholar 

  39. Hollander E, Liebowitz MR, Winchel R, Klumler A, Klein DF. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. Am J Psychiatry 1989; 146: 768–770.

    CAS  Google Scholar 

  40. Srinivasagam NM, Plotnicov KH, Greeno C, Weltzin TE, Rao R, Kaye WH. Persistent perfectionism, symmetry, and exactness in anorexia nervosa after long-term recovery. Am J Psychiatry, 1995; 152: 1630–1634.

    CAS  Google Scholar 

  41. Crisp AH, Lacey JH, Crutchfield M. Clomipramine and “drive” in people with anorexia nervosa. Br J Psychiatry 1987; 150: 355–358.

    Article  CAS  Google Scholar 

  42. Stone CA, Wenger HC, Ludden CT. Antiserotonin-antihistamine properties of cyproheptadine. J Pharm Exp Ther 1961; 131: 73–81.

    CAS  Google Scholar 

  43. Goldberg SC, Halmi KA, Eckert ED. Cyproheptadine in anorexia nervosa. Brit J Psychol 1979; 134: 67–70.

    Article  CAS  Google Scholar 

  44. Halmi KA, Eckert E, Falk JR. Cyproheptadine for anorexia nervosa. Lancet 1982; 1: 1357–1358.

    Article  CAS  Google Scholar 

  45. Halmi KA, Eckert ED, LaDu, TJ, Cohen J. Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 1986; 43: 177–181.

    Article  CAS  Google Scholar 

  46. Gwirtsman HE, Guze BH, Yager J, Gainsley B. Fluoxetine treatment of anorexia nervosa: an open clinical trial. J Clin Psychiatry 1990; 51: 378–382.

    CAS  Google Scholar 

  47. Kaye WH, Weltzin TE, Hsu LKG, Bulik CM. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psych 1991; 52: 464–471.

    CAS  Google Scholar 

  48. Ferguson CP, La Via MC, Crossan PJ, Kaye WH. Are SSRI’s effective in underweight anorexia nervosa? Int J Eat Disord, in press.

    Google Scholar 

  49. Attia E, Haiman C, Walsh BT, Flater SR. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry 1998; 155: 548–551.

    CAS  Google Scholar 

  50. Schweiger V, Warnoff M, Pahl J, Pirke K. Effects of carbohydrate and protein meals on plasma large neutral amino acids, glucose and insulin plasma levels of anorectic patients. Metabolism 1986; 35 (2): 938–943.

    Article  CAS  Google Scholar 

  51. Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH. CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain. Biol Psychiatry 1988; 23 (1): 102–105.

    Article  CAS  Google Scholar 

  52. Fink G, Summner BEH. Oestrogen and mental state. Nature 1996; 383: 306.

    Article  CAS  Google Scholar 

  53. McQueen JK, Wilson H, Dow RC, Fink GJ. Oestradiol-17 beta increases serotonin transporter (SERT) binding sites and SERT mRNA expression in discrete regions of female rat brain. J Physiol (Lond) 1996; 495: 114.

    Google Scholar 

  54. Tollefson GD. Selective serotonin reuptake inhibitors. In: Schatzberg AF, Memeroff CB, eds. Textbook of Psychopharmacology. American Psychiatric Press, Washington, DC, 1995.

    Google Scholar 

  55. Kaye WH, Ebert MH, Raleigh M, Lake R. Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch Gen Psychiatry 1984; 41 (4): 350–355.

    Article  CAS  Google Scholar 

  56. Pollice C, Kaye WH, Greeno CG, Weltzin TE. Relationship of depression, anxiety, and obsessionality to state of illness in anorexia nervosa. Int J Eat Disord 1997; 21: 367–376.

    Article  CAS  Google Scholar 

  57. American Psychiatric Association. Practice guideline for eating disorders: I. disease definition, epidemiology, and natural history. Am J Psychol 1993; 150 (2): 212–228.

    Google Scholar 

  58. Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL. Serotonergic responsivity in obsessive-compulsive disorder. Arch Gen Psychiatry 1988; 45: 167–172.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Walter H. Kaye
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lilly Research Laboratories, Indiana University School of Medicine, Indianapolis, IN, USA

    David J. Goldstein MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kaye, W.H. (1999). Pharmacologic Therapy for Anorexia Nervosa. In: Goldstein, D.J. (eds) The Management of Eating Disorders and Obesity. Nutrition ◊ and ◊ Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-694-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-694-2_7

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-6761-2

  • Online ISBN: 978-1-59259-694-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation